Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Villeneuve

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Hospital Pharmacy|September 8, 2025
Eric Villeneuve
The Canadian Journal of Hospital Pharmacy|September 8, 2025
Pharmacotherapy Specialists: Let Us Own Our Area of Expertise!Eric Villeneuve
The Annals of Pharmacotherapy|February 25, 2005
Glycoprotein IIb/IIIa inhibitors in patients with end-stage renal diseaseEric Villeneuve, Rubina Sunderji
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|October 26, 2016
In Response to: "The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty"Juliana Lombardi, Eric Villeneuve, Sophie Gosselin
Annals of Emergency Medicine|February 25, 2017
There is No Contraindication to Emergent Glucose AdministrationEric Villeneuve, Sophie Gosselin, Robert S Hoffman
Clinical Toxicology (Philadelphia, Pa.)|October 7, 2016
Letter in response to "Idarucizumab for dabigatran overdose"Josh J Wang, Eric Villeneuve, Sophie Gosselin
Pain Medicine (Malden, Mass.)|March 25, 2017
Opioid Overdose Risk in Low-Wage Online WorkersJosh J Wang, Eric Villeneuve, Sophie Gosselin
The New England Journal of Medicine|December 24, 2016
Andexanet Alfa for Factor Xa Inhibitor ReversalJosh J Wang, Sophie Gosselin, Eric Villeneuve
The American Journal of Emergency Medicine|February 8, 2020
Studying the relevance of beers criteria to the contemporary EDStefano Barillaro, Madeleine Genest, Eric Villeneuve, et al.
The American Journal of Emergency Medicine|February 5, 2020
Real-world utilization of andexanet alfaCaroline Bernard, Eric Villeneuve, Madeleine Genest, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Hospital Pharmacy|September 8, 2025
Eric Villeneuve
The Canadian Journal of Hospital Pharmacy|September 8, 2025
Pharmacotherapy Specialists: Let Us Own Our Area of Expertise!Eric Villeneuve
The Annals of Pharmacotherapy|February 25, 2005
Glycoprotein IIb/IIIa inhibitors in patients with end-stage renal diseaseEric Villeneuve, Rubina Sunderji
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|October 26, 2016
In Response to: "The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty"Juliana Lombardi, Eric Villeneuve, Sophie Gosselin
Annals of Emergency Medicine|February 25, 2017
There is No Contraindication to Emergent Glucose AdministrationEric Villeneuve, Sophie Gosselin, Robert S Hoffman
Clinical Toxicology (Philadelphia, Pa.)|October 7, 2016
Letter in response to "Idarucizumab for dabigatran overdose"Josh J Wang, Eric Villeneuve, Sophie Gosselin
Pain Medicine (Malden, Mass.)|March 25, 2017
Opioid Overdose Risk in Low-Wage Online WorkersJosh J Wang, Eric Villeneuve, Sophie Gosselin
The New England Journal of Medicine|December 24, 2016
Andexanet Alfa for Factor Xa Inhibitor ReversalJosh J Wang, Sophie Gosselin, Eric Villeneuve
The American Journal of Emergency Medicine|February 8, 2020
Studying the relevance of beers criteria to the contemporary EDStefano Barillaro, Madeleine Genest, Eric Villeneuve, et al.
The American Journal of Emergency Medicine|February 5, 2020
Real-world utilization of andexanet alfaCaroline Bernard, Eric Villeneuve, Madeleine Genest, et al.
Pageof 4